Press Releases

Press Releases

04.24.18
OpGen Highlights Acuitas® Analytical Validation Data for Rapidly Predicting Antibiotic Resistance Using Drug Resistance Gene Profiles at ECCMID
04.19.18
OpGen Completes Rapid Testing Clinical Trial in Colombia and Expands International Operations
03.15.18
OpGen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides a Business Update
03.13.18
OpGen Announces Collaborator in Verification Study for Acuitas® Test
03.05.18
OpGen Announces Date of Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call
03.01.18
OpGen to Present at the Cowen and Company 38th Annual Health Care Conference
02.13.18
OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas® Tests
02.07.18
OpGen Announces Closing of $12 Million Public Offering
02.05.18
OpGen Regains Compliance With Nasdaq Listing Requirements
02.02.18
OpGen Announces Pricing of $12 Million Upsized Public Offering